Consensus Stryker Corporation London S.E.

Stocks

0R2S

US8636671013

Medical Equipment, Supplies & Distribution

Delayed London S.E. 11:30:02 22/09/26 pm AEST			5-day change	1st Jan Change
277.33 ^USD	+0.85%		-1.46%	-21.61%

22/09	TD Cowen Adjusts Price Target on Stryker to $298 From $355, Keeps Hold Rating	MT
22/09	Jefferies Adjusts Price Target on Stryker to $405 From $440, Keeps Buy Rating	MT

c2e72a062d235ff2427dbe846a.2c24XfRjUtRQQMx1Fadr7jE9YJ4jVuJLKxd4JwzFpwY.u4DhJ58mKKQ_cZwqQJQTuHJ-M_hGDKUqHWM1a16AxE_hmfYTljIKhmEpjQ~2a408985d92872c652a023efc67b101b

Analysts' recommendations: Stryker Corporation

22/09	TD Cowen Adjusts Price Target on Stryker to $298 From $355, Keeps Hold Rating	MT
22/09	Jefferies Adjusts Price Target on Stryker to $405 From $440, Keeps Buy Rating	MT
21/09	Raymond James Adjusts Price Target on Stryker to $330 From $370, Keeps Outperform Rating	MT
18/09	Canaccord Genuity Adjusts Price Target on Stryker to $385 From $400, Keeps Buy Rating	MT
18/09	Stryker Facing Promising Setup Next Year, Trading Upside Limited in 2026, RBC Says	MT
14/09	Bernstein Adjusts Price Target on Stryker to $385 From $420, Keeps Outperform Rating	MT
09/09	Citigroup Adjusts Stryker Price Target to $360 From $399, Maintains Buy Rating	MT
09/09	Wells Fargo Adjusts Price Target on Stryker to $348 From $418, Keeps Overweight Rating	MT
09/09	BMO Capital Adjusts Price Target on Stryker to $317 From $369, Keeps Outperform Rating	MT
18/08	Leerink Partners Adjusts Price Target on Stryker to $403 From $407, Maintains Outperform Rating	MT
13/08	Citigroup Adjusts Price Target on Stryker to $399 From $385, Maintains Buy Rating	MT
06/08	Rothschild & Co Redburn Adjusts Stryker Price Target to $360 From $346	MT
04/08	UBS Adjusts Stryker Price Target to $382 From $400, Maintains Buy Rating	MT
03/08	Analyst recommendations: Chevron, Linde, RTX, Colgate-Palmolive, American Electric Power...
31/07	RBC Cuts Price Target on Stryker to $420 From $435, Keeps Outperform Rating	MT
31/07	Evercore ISI Adjusts Stryker Price Target to $355 From $350, Maintains Outperform Rating	MT
31/07	Truist Lifts Price Target on Stryker to $340 From $330, Keeps Hold Rating	MT
31/07	Raymond James Adjusts Price Target on Stryker to $370 From $383, Maintains Outperform Rating	MT
31/07	Jefferies Adjusts Price Target on Stryker to $440 From $455, Maintains Buy Rating	MT
31/07	BTIG Adjusts Price Target on Stryker to $358 From $371, Maintains Buy Rating	MT
31/07	Piper Sandler Adjusts Price Target on Stryker to $390 From $420, Maintains Overweight Rating	MT
31/07	JPMorgan Adjusts Price Target on Stryker to $350 From $400, Maintains Overweight Rating	MT
31/07	Bernstein Adjusts Price Target on Stryker to $420 From $410, Maintains Outperform Rating	MT
30/07	The Fed Gets a Better Inflation Number
29/07	UBS Upgrades Stryker to Buy From Neutral, Adjusts Price Target to $400 From $380	MT

More recommendations

Medical Devices & Implants

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
STRYKER CORPORATION			+34.14%
SMITH & NEPHEW PLC			+23.29%
GLAUKOS CORPORATION			+24.29%
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.			+42.9%
DOUBLE MEDICAL TECHNOLOGY INC.	-	-	+28.17%
INSPIRE MEDICAL SYSTEMS, INC.			-11.92%
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.			+48.69%
Average			+27.08%
Weighted average by Cap.			+32.17%